4Van de Rijn M, Barr FG, Xiong QB,et al. Poorly differentiated synovial sarcoma: an analysis of clinical,pathologic, and molecular genetic features [J]. Am J Surg Paphol,1999,23( 1 ) : 106-112.
5Folpe AL, Sehmidt RA, Chapman D,et al. Poorly differentiated synovial sarvoma: immunohistochemical disti-nction from primitive neuroectodermal tumors and high grade maligmant peripheral nerve sheath tumors [J].Am J Surg Pathol, 1998,22(6):673-682.
二级参考文献20
1[1]Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 4th ed, St Louis: Mosby, 2001
2[2]Clark J, Rocques PJ, Crew AJ et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nature Genet, 1994; 7:502～8
3[3]Argani P, Zakawski MF, Klimstra DS et al. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol, 1998;11:65～71
4[4]Tsuji S, Hisaoka M, Morimitsu Y et al. Detection for SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol, 1998;153:1807～12
5[5]van de Rijn M, Barr FG, Xiong QB et al. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol, 1999;23: 106～12
6[6]Meis-Kindblom JM, Stenman G, Kindblom LG. Differential diagnosis of small round cell tumors. Semin Diagn Pathol, 1996; 13: 213～41
7[7]Bergh P, Meis-Kindblom JM, Gherlinzoni F et al. Synovial sarcoma: identification of low and high risk groups. Cancer, 1999; 85: 2596～607
8[8]Folpe AL, Schmidt RA, Chapman D et al. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol, 1998; 22: 673～82
9[9]Hirakawa N, Naka T, Yamamoto I et al. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol, 1996; 27:1060～5
10[10]Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol, 1998;22: 863～72
7Amary MF, Berisha F, Bemardi l"del C, el al. DeLection of SSIS- SSX fusicm transcripts in Ibrmalin-fixed paraffin-embedded neoplasms: analysis of ccmventional RT-PCR, qlIT-PC|/and dual color FISH as diagnostic tools for swmvial sarcoma. Med Pallml. 2007, 20: 482-496.
8Sandberg AA, Bridge JA Updates on the cytogenetics anti moleular genetics of bone and soft tissue lumors. Synovial sarcoma. Cancer Genet Cytogeoet, 2002, 133 : 1-23.
9Coindre .IM. Pelmus M, Hostein I,et al .Shoulds molecular testing be required for diagnosing synovial sarcoma?A prospective study of 204 cases. Cancer, 2003, 98: 2700-2707.
10dos Santos NR, de Bruijn DR, Bah'roans M, cl al. Nuclear localization of SYT. SSX and the s.vnovial Sarcomaassotia/ed SYT-SSX fusion proteins. Hum Mol Genet, 1997, 6: 1549-1558.
